SR 30 — A resolution to designate May 4-10, 2025, as Tardive Dyskinesia Awareness Week.

SR-30,MICHIGAN As Adopted by Senate, April 22, 2025 SENATE RESOLUTIONSenate NO.Resolution No.

30 Offered by Senators Santana, Geiss and McMorrow offeredA theRESOLUTION followingTO resolution:DESIGNATE MAY 4-10, 2025 , AS TARDIVE DYSKINESIA AWARENESS WEEK WHEREAS, Serious mental illnesses such as bipolar disorder, major depressive disorders, and schizophrenia require treatment with antipsychotic medications for effective management, while antipsychotic prescribing rates continue to rise;

Aand resolutionWHEREAS, toWhile designateprolonged Mayantipsychotic 4-10,use 2025,may asbe Tardiveessential Dyskinesiafor Awarenessthe Week.treatment of certain conditions, it is often associated with tardive dyskinesia (TD), a condition marked by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, or extremities;

Whereas,and SeriousWHEREAS, mentalThose illnessesat sucha ashigher bipolarrisk disorder,of majorTD depressiveinclude disorders,individuals andolder schizophreniathan require55, treatmentBlack individuals, women, individuals with antipsychoticmood medicationsor forsubstance effectiveuse management,disorders, whileintellectual antipsychoticdisabilities, prescribingor ratescentral continuenervous tosystem rise;injuries, and those with high cumulative antipsychotic exposure;

and Whereas,WHEREAS, WhileApproximately prolonged60 antipsychoticpercent useof may be essential for the treatmentestimated of800,000 certainAmerican conditions,adults itliving is often associated with tardiveTD dyskinesiaremain (TD),undiagnosed; a condition marked by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, or extremities;

and Whereas,WHEREAS, ThoseEven atmild a higher risk of TD includesymptoms individualscan olderbe thanstigmatizing 55,and Blackimpair individuals,physical, women,social, individualsand withemotional moodwell-being, orunderscoring TD_SR30_AA_1the 9mfitwurgency 1of substanceearly usescreening, disorders,detection, intellectual disabilities, or central nervous system injuries, and thoseintervention; with high cumulative antipsychotic exposure;

and Whereas,WHEREAS, ApproximatelyThe 60American percentPsychiatric ofAssociation therecommends estimatedroutine 800,000TD Americanscreening adultsin livingtheir withclinical TDguidelines remainfor undiagnosed;antipsychotic treatment.

and Whereas, Even mild TD symptoms can be stigmatizing and impair physical, social, and emotional well-being, underscoring the urgency of early screening, detection, and intervention;

and Whereas, The American Psychiatric Association recommends routine TD screening in their clinical guidelines for antipsychotic treatment.

and Whereas,WHEREAS, FDA-approved treatments for TD can provide options for symptom management and improved quality of life for many individuals living with TD;

and Whereas,WHEREAS, We encourage TD screening education and awareness for health care providers, patients, and care partners to help ensure patients prescribed antipsychotics receive care and support that aligns with clinical best practices, including regular TD screenings;

now, therefore, be it ResolvedRESOLVED byBY theTHE Senate,SENATE, That the members of this legislative body designate May 4-10, 2025, as Tardive Dyskinesia Awareness Week;

and be it further Resolved,RESOLVED,That That we encourage anyone experiencing uncontrollable, abnormal, and repetitive movements to consult their healthcare provider regarding their symptoms.

TD_SR30_AA_1Adopted 9mfitwby the Senate, April 22, 2025.

Secretary of the Senate